We are live on
!
Find out more
RCA
Rowland Carmichael Advisors Portfolio holdings
AUM
$316M
1-Year Est. Return
18.07%
This Fund
S&P 500
This Quarter
Est. Return
+2.96%
1 Year Est. Return
+18.07%
3 Year Est. Return
+39.01%
5 Year Est. Return
+76.16%
10 Year Est. Return
–
AUM
$159M
AUM Growth
+$50.5M
(+47%)
Cap. Flow
+$47.2M
Cap. Flow
% of AUM
29.73%
Top 10 Holdings %
Top 10 Hldgs %
17.89%
Holding
316
New
103
Increased
92
Reduced
59
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$1.51M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.5M |
| 3 |
Wynn Resorts
WYNN
|
+$1.03M |
| 4 |
AGN
Allergan plc
AGN
|
+$992K |
| 5 |
Newell Brands
NWL
|
+$991K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Floating Rate Bond ETF
FLOT
|
+$677K |
| 2 |
Bank of Montreal
BMO
|
+$616K |
| 3 |
Chevron
CVX
|
+$614K |
| 4 |
Walt Disney
DIS
|
+$557K |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$435K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.04% |
| 2 | Real Estate | 9.76% |
| 3 | Industrials | 8.57% |
| 4 | Financials | 8.54% |
| 5 | Consumer Staples | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
AstraZeneca
AZN
$263B
| $223K | 0.14% |
+3,698
| New | +$215K |
|
202
Omega Healthcare
OHI
$15.4B
| $220K | 0.14% |
6,466
-200
| -3% | -$6.67K |
|
203
Berkshire Hathaway Class A
BRK.A
$1.07T
| $217K | 0.14% |
1
-2
| -67% | -$429K |
|
204
BWX Technologies
BWXT
$16B
| $215K | 0.14% |
+6,015
| New | +$206K |
|
205
Macerich
MAC
$7.32B
| $213K | 0.13% |
+2,500
| New | +$196K |
|
206
TotalEnergies
TTE
$193B
| $213K | 0.13% |
+4,432
| New | +$212K |
|
207
Novartis
NVS
$295B
| $212K | 0.13% |
+2,873
| New | +$198K |
|
|
CHL
208
DELISTED
China Mobile Limited
CHL
| $211K | 0.13% |
+3,647
| New | +$205K |
|
209
Alexandria Real Estate Equities
ARE
$8.88B
| $207K | 0.13% |
+2,000
| New | +$191K |
|
|
AHRT
210
AH Realty Trust
AHRT
$534M
| $206K | 0.13% |
+15,000
| New | +$182K |
|
211
Apple Hospitality REIT
APLE
$3.96B
| $203K | 0.13% |
+10,793
| New | +$202K |
|
212
Entergy
ETR
$54.1B
| $203K | 0.13% |
+4,980
| New | +$191K |
|
213
Tanger
SKT
$4.82B
| $202K | 0.13% |
+5,030
| New | +$183K |
|
214
Schwab US REIT ETF
SCHH
$11.7B
| $201K | 0.13% |
9,242
-280
| -3% | -$5.78K |
|
215
Eli Lilly
LLY
$1.07T
| $200K | 0.13% |
+2,537
| New | +$191K |
|
216
Schwab US Large- Cap ETF
SCHX
$70.9B
| $199K | 0.13% |
24,024
+20,064
| +507% | +$165K |
|
217
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
| $189K | 0.12% |
+2,360
| New | +$184K |
|
|
ORAN
218
DELISTED
Orange
ORAN
| $184K | 0.12% |
+11,185
| New | +$187K |
|
219
Prospect Capital
PSEC
$1.06B
| $178K | 0.11% |
22,710
| – | – |
|
220
Cousins Properties
CUZ
$5.29B
| $177K | 0.11% |
+6,022
| New | +$179K |
|
221
iShares Gold Trust
IAU
$63B
| $173K | 0.11% |
+6,797
| New | +$165K |
|
222
Vanguard FTSE Pacific ETF
VPL
$8.05B
| $153K | 0.1% |
+2,750
| New | +$153K |
|
223
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
| $152K | 0.1% |
1,237
-8
| -0.6% | -$959 |
|
224
MBIA
MBI
$288M
| $146K | 0.09% |
+21,361
| New | +$159K |
|
225
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.63B
| $145K | 0.09% |
3,616
-55
| -1% | -$2.18K |
|
Similar funds
TFM
FRGX
AWW
NFG
MCFIG
SM
SIVVM
RA
Rowland Carmichael Advisors's Q2 2016 Portfolio in Review
As of Q2 2016, Rowland Carmichael Advisors held 316 positions worth $159M, up 47% from $108M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Rowland Carmichael Advisors deployed $47.2M of net new capital in Q2 2016, opening 103 new positions and adding to 92 existing holdings. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 17,148 shares worth $1.53M.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, up from 8.9% a quarter earlier, followed by Real Estate and Industrials.
On the sell side, the largest reduction was iShares Floating Rate Bond ETF, an estimated $677K trimmed.
- Rowland Carmichael Advisors's largest Q2 2016 buy was Vanguard Intermediate-Term Corporate Bond ETF: 17,148 shares worth $1.53M.
- Rowland Carmichael Advisors added most to SLB Ltd in Q2 2016, an estimated $1.51M increase.
- Rowland Carmichael Advisors's biggest Q2 2016 reduction was iShares Floating Rate Bond ETF, cutting an estimated $677K.
- Rowland Carmichael Advisors fully exited Bank of Montreal in Q2 2016, selling an estimated $616K.
- Rowland Carmichael Advisors's ten largest holdings make up 18% of its $159M portfolio in Q2 2016.
- Rowland Carmichael Advisors opened 103 new positions and closed 21 in Q2 2016.
- Rowland Carmichael Advisors's portfolio value rose 47% quarter-over-quarter to $159M.
Based on Rowland Carmichael Advisors's 13F filing for Q2 2016, filed 10 Feb 2020.